Jext (Epinephrine Bitartrate)

Epinephrine stimulates alpha‑1, alpha‑2, beta‑1 and beta‑2 adrenergic receptors. Alpha‑1 activation causes vasoconstriction, raising blood pressure and reducing airway edema. Beta‑1 stimulation increases heart rate and contractility, while beta‑2 activation relaxes bronchial smooth muscle and inhibits mast‑cell mediator release, collectively reversing the symptoms of anaphylaxis.

The dose of Jext is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical situation. In most guidelines, a single 0.3 mg intramuscular injection is recommended for adults and children weighing at least 15 kg, with repeat dosing if symptoms persist.

The pregnancy safety category for epinephrine is listed as unknown. Use during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss possible risks with the patient.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Jext contains the same 0.3 mg epinephrine dose as other leading auto‑injectors such as EpiPen, but it is manufactured to EU standards and supplied by GNH India under GDP compliance. Differences may lie in device design, packaging, and regulatory approvals, while the pharmacological effect remains equivalent.

Jext should be stored at ambient temperature, below 25 °C, in its original protective case. Keep the device away from moisture, direct sunlight and extreme temperatures. Do not expose it to freezing conditions, and inspect the auto‑injector for any damage before use.

Jext is administered by intramuscular injection into the outer thigh (vastus lateralis), even through clothing if necessary. The user should press the device firmly against the thigh until a click is heard, hold it in place for the recommended time (usually 3 seconds), then remove and massage the injection site briefly.

The most serious risks include cardiac arrhythmias, hypertensive crisis, and pulmonary edema, especially in patients with underlying cardiovascular disease. These events require immediate medical attention. Monitoring after administration is essential to detect any worsening of symptoms or new adverse reactions.

Jext should not be used by individuals with a known hypersensitivity to epinephrine or any component of the auto‑injector. Caution is advised for patients with uncontrolled hypertension, certain cardiac arrhythmias, or severe coronary artery disease. Pediatric use is limited to children weighing at least 15 kg, and dosing decisions must follow clinical guidelines.